Serono Purchases Caliper Microfluidic System

Jul 21, 2003

NEW YORK, July 21 - Biotech firm Serono has purchased a microfluidic-based drug discovery system from Caliper Technologies, Caliper said today.

Serono will use the Caliper 250 drug discovery system, which is based on Caliper's microfluidic LabChip technology, to develop kinase assays.

Caliper completed its acquisition of lab automation firm Zymark last week.

Breaking News

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.